10:30

INTRODUCTION: CALCIFIED CRURAL ARTERIES: OVERALL PROFILE OF PATIENTS AND DIFFERENCES OF OTHER LEAD TYPES

Venermo M. *

10:36

PLANNING FEMOROPEDAL BYPASS: HOW TO EVALUATE THE OUTFLOW ARTERY? VALUE OF  CO2 ANGIO, DUS AND CONVENTIONAL DSA.

Behrendt C.A. *

10:44

TECHNICAL TIPS AND TRICKS TO DO BYPASS SURGERY TO HEAVILY NON-COMPRESSIBLE CALCIFIED CRURAL ARTERIES:

Farber A. *

10:52

ATHERECTOMY TREATMENT ALGORYTHM FOR COMPLEX INFRAPOPLITEAL DISEASE.

Patrone L. *

11:00

DIABETIC PATIENTS WITH CLTI AND LARGE FOOT NECROSIS: WHEN THERE IS NO TIME FOR ENDOVASCULAR FIRST STRATEGY.

Noronen K. *

11:07

ROLE AND VALUE OF VEIN ARTERIALIZATION (OPEN AND ENDO TECHNOLOGIES)

11:15

DEBATE: NO OPTION FOR GSV AND SINGLE SEGMENT VEIN. PTFE IS BETTER THAN SPLICED VEIN: PRO THE MOTION

11:21

DEBATE: NO OPTION FOR GSV AND SINGLE SEGMENT VEIN. PTFE IS BETTER THAN SPLICED VEIN: AGAINST THE MOTION

Saarinen E. *

11:27

PANEL DISCUSSION